XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Cash Flows from Operating Activities:            
Net loss $ 78,287 $ (1,894,642) $ (820,759) $ (527,360) $ (1,552,805) $ (2,007,578)
Adjustments to reconcile net loss to net cash used in operating activities:            
Interest earned on investments held in Trust Account         (301,859) (470,150)
Change in fair value of PIPE Forward Contract Derivative (700,506)       (170,666)  
Changes in operating assets and liabilities:            
Prepaid and other current assets         (17,500) 397,231
Accounts payable and accrued expenses         957,989 1,282,429
Advances from related parties         87,037  
Income taxes payable           83,026
Net cash used in operating activities         (640,577) (715,042)
Cash Flows from Investing Activities:            
Investment of cash into Trust Account         (350,000)  
Cash withdrawn from Trust Account to pay franchise and income taxes         59,586  
Net cash used in investing activities         (290,414)  
Cash Flows from Financing Activities:            
Advances from related party         8,000  
Proceeds from promissory note - related party         576,500  
Proceeds from promissory note         250,000  
Financing costs paid - promissory note         (10,000)  
Net cash provided by financing activities         824,500  
Net Change in Cash         (106,491) (715,042)
Cash - Beginning of period   $ 106,998   $ 760,012 106,998 760,012
Cash - End of period 507   $ 44,970   507 $ 44,970
Non-cash investing and financing activities:            
Common stock issued from legal settlement         214,200  
Bridge Notes            
Adjustments to reconcile net loss to net cash used in operating activities:            
Change in fair value of derivative 28,838       (123,265)  
Changes in operating assets and liabilities:            
Accrued interest expense         399,416  
Investor Note            
Adjustments to reconcile net loss to net cash used in operating activities:            
Change in fair value of derivative $ (4,796)       (1,697)  
Changes in operating assets and liabilities:            
Accrued interest expense         82,773  
Non-cash investing and financing activities:            
Financing costs included         60,000  
Warrants issued as financing cost         40,130  
Common stock issued as financing cost in Note         $ 78,349